Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.

Our Approach

We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.

Together, we can bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Providers


We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.

#6846 - COTA Healthcare homepage redesign - Payers


We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.

#6846 - COTA Healthcare homepage redesign - Life Sciences

Life Sciences

Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.

“COTA was founded in 2011 by oncologists, engineers, and data scientists, with one aim in mind: to transform cancer care so that every patient gets the right treatment. That’s not a mission we can achieve alone. We are committed to working with providers, payers, life sciences companies, patients and the FDA to change how cancer is studied and treated.”
Andrew Pecora, M.D. Founder & Chairman

Necessity is the Mother of Invention with Paul Simms

In this episode of the Real World Talk podcast, Zoe Li talks to Paul Simms, a Managing Partner at Impatient Health.

For 17 years, Paul ran a company called eyeforpharma. As he says, it was helpful because it put him in touch with people across the industry and allowed him to understand the trends and the beliefs.

Paul and Zoe discuss why the pharma industry is science-centric and not patient-centric. Paul also says if we want to understand the problem, we need to experience it.

Latest Resources

COTA Adds New Life Sciences Leadership to Support Growth in Demand for Oncology Real-World Data

To support growing demand for oncology real-world data, COTA is honored to announce a new addition to the team – Paige Whitney. Paige will serve as Vice President of Life Sciences at COTA.

Researchers Look for Ways to Make Drug Trials More Diverse

Pharmaceutical researchers are turning to technology to broaden access to experimental treatments, and make clinical trials more equitable in terms of their inclusion of minorities

Let’s work together to transform cancer care.